NDC 68084-604-11 - Desmopressin Acetate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68084-604
- Requested NDC
- 68084-604-11
- Package NDCs from labels
- 68084-604-11, 68084-604-21
- Manufacturer
- American Health Packaging
- Effective date
- 2023-03-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Desmopressin Acetate - American Health Packaging | American Health Packaging | 2023-03-20 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68084-604-11 | EA - Each | 68084-604 | 07e9593c-eb20-4356-9097-50ed4b0e74e2 | 1 | 2013-02-13 |
| 68084-604-21 | EA - Each | 68084-604 | a3224d68-9c24-4db0-bb17-c91fd7b6b001 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| DESMOPRESSIN ACETATE | ACTIVE INGREDIENT | XB13HYU18U | DESMOPRESSIN ACETATE TABLET [AMERICAN HEALTH PACKAGING] | 3 | |
| DESMOPRESSIN | ACTIVE MOIETY | ENR1LLB0FP | DESMOPRESSIN ACETATE TABLET [AMERICAN HEALTH PACKAGING] | 3 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | DESMOPRESSIN ACETATE TABLET [AMERICAN HEALTH PACKAGING] | 3 | |
| BUTYLATED HYDROXYTOLUENE | INACTIVE INGREDIENT | 1P9D0Z171K | DESMOPRESSIN ACETATE TABLET [AMERICAN HEALTH PACKAGING] | 3 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | DESMOPRESSIN ACETATE TABLET [AMERICAN HEALTH PACKAGING] | 3 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | DESMOPRESSIN ACETATE TABLET [AMERICAN HEALTH PACKAGING] | 3 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | DESMOPRESSIN ACETATE TABLET [AMERICAN HEALTH PACKAGING] | 3 | |
| POVIDONES | INACTIVE INGREDIENT | FZ989GH94E | DESMOPRESSIN ACETATE TABLET [AMERICAN HEALTH PACKAGING] | 3 | |
| STARCH, POTATO | INACTIVE INGREDIENT | 8I089SAH3T | DESMOPRESSIN ACETATE TABLET [AMERICAN HEALTH PACKAGING] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Desmopressin Acetate | DESMOPRESSIN ACETATE | Sun Pharmaceutical Industries, Inc. | 9fd48eec-aa24-4888-b99f-d409ada958a7 | 2022-08-24 | Boxed warning, Warnings, Adverse reactions | XB13HYU18U |
| Desmopressin Acetate | DESMOPRESSIN ACETATE | Dr. Reddy's Laboratories Inc. | 60dd8694-58d8-d88e-26f2-f28baa53787e | 2022-07-26 | Boxed warning, Warnings, Adverse reactions | XB13HYU18U |
| Desmopressin Acetate | DESMOPRESSIN ACETATE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | e87b6cfd-5677-4398-883d-7ced5dd678ef | 2022-03-30 | Warnings, Adverse reactions | XB13HYU18U |
| Desmopressin Acetate | DESMOPRESSIN ACETATE | Bauch & Lomb Incorporated | 8ca799f1-7029-4527-9ab4-7512504bb8e2 | 2021-09-01 | Warnings, Adverse reactions | XB13HYU18U |
| DDAVP | DESMOPRESSIN ACETATE | Ferring Pharmaceuticals Inc. | 6d55baa9-2b62-469c-93ae-3909ab249332 | 2021-02-03 | Warnings, Adverse reactions | XB13HYU18U |
| desmopressin acetate | DESMOPRESSIN ACETATE | Sun Pharmaceutical Industries, Inc. | 2dc2cec8-6953-4a33-9356-11534fba1fb8 | 2020-01-23 | Warnings, Adverse reactions | XB13HYU18U |
| DESMOPRESSIN ACETATE | DESMOPRESSIN ACETATE | Dr.Reddys' Laboratories Inc | 15179e0c-f677-307f-d1e1-5910de4c212f | 2019-11-30 | Warnings, Adverse reactions | XB13HYU18U |
| Desmopressin Acetate | DESMOPRESSIN ACETATE | Glenmark Pharmaceuticals Inc.,USA | 7a26b415-77cd-4b2f-9c76-fa52d2eb6be6 | 2019-06-28 | Warnings, Adverse reactions | XB13HYU18U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.